0.00Open0.00Pre Close0 Volume0 Open Interest3.00Strike Price0.00Turnover0.00%IV177.78%PremiumSep 20, 2024Expiry Date0.00Intrinsic Value100Multiplier18DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.32Leverage Ratio--Theta--Rho--Eff Leverage--Vega
CEL-SCI Stock Discussion
Head and neck cancers (HNC) remain a global health challenge, impacting thousands of individuals each year. Advances in immunotherapy have offered new hope for improving patient outcomes, particularly concerning survival rates. In this context...
No comment yet